Suppr超能文献

镰状细胞病成人的骨密度

Bone mass density in adults with sickle cell disease.

作者信息

Sarrai Mona, Duroseau Herold, D'Augustine Jean, Moktan Sabita, Bellevue Rita

机构信息

The Comprehensive Sickle Cell/Thalassemia Program and the Department of Medicine, New York Methodist Hospital, Brooklyn, NY, USA.

出版信息

Br J Haematol. 2007 Feb;136(4):666-72. doi: 10.1111/j.1365-2141.2006.06487.x.

Abstract

Sickle cell disease (SCD) leads to many complications including osteoporosis and osteopenia. We studied the prevalence and predisposing factors of low bone mass density (BMD) in adults with SCD. In this retrospective study, dual X-ray absorptiometry bone scans were used to determine BMD in the lumbar spine, femoral neck and ultra distal radius of 103 patients (73 females, 30 males, aged 15-80 years). Chart reviews and a patient questionnaire were used to collect patient characteristics, disease course and severity, and low BMD risk factors. The 79.6% of patients (mean age 36.5 +/- 12.5 years) had an abnormal BMD, with a predilection for the lumbar spine (P = 0.001). Analysis by 3 (low BMD versus very low BMD versus normal) or by 2 groups (abnormal versus normal) showed that abnormal BMD was associated with lower body mass index (BMI) (P = 0.003), lower Hb level (P = 0.001) and higher ferritin (P = 0.003). Low BMD patients were more likely to be SS, SC or Sbeta(0)thal than Sbeta(+)thal (P = 0.022). Abnormal BMD was not related to age, sex, menarche, SCD complications, number of crises, iron overload, treatment with hydroxycarbamide or desferal, renal disease, smoking or alcohol. Patients treated with hydroxycarbamide for at least 6 months were more likely to have an abnormal BMD. In this SCD population, abnormal BMD seemed to be independent of sex, age and menopause, whereas BMI, ferritin level, Hb type and level appeared to play a major role.

摘要

镰状细胞病(SCD)会引发许多并发症,包括骨质疏松和骨质减少。我们研究了成年SCD患者低骨密度(BMD)的患病率及相关危险因素。在这项回顾性研究中,采用双能X线吸收法骨扫描测定了103例患者(73名女性,30名男性,年龄15 - 80岁)腰椎、股骨颈和桡骨超远端的骨密度。通过查阅病历和患者问卷调查收集患者特征、病程和严重程度以及低骨密度危险因素。79.6%的患者(平均年龄36.5±12.5岁)骨密度异常,以腰椎受累为主(P = 0.001)。按3组(低骨密度组与极低骨密度组与正常组)或2组(异常组与正常组)分析显示,骨密度异常与较低的体重指数(BMI)(P = 0.003)、较低的血红蛋白(Hb)水平(P = 0.001)和较高的铁蛋白水平(P = 0.003)相关。低骨密度患者为SS型、SC型或Sβ0地中海贫血型的可能性高于Sβ +地中海贫血型(P = 0.022)。骨密度异常与年龄、性别、初潮、SCD并发症、危象次数、铁过载、羟基脲或去铁胺治疗、肾脏疾病、吸烟或饮酒无关。接受羟基脲治疗至少6个月的患者骨密度异常的可能性更大。在这个SCD人群中,骨密度异常似乎与性别、年龄和绝经无关,而BMI、铁蛋白水平、Hb类型和水平似乎起主要作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验